Pentwater Capital Management LP Exact Sciences Corp Transaction History

Pentwater Capital Management LP

  • $9.58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$37.9 - $104.44 $379,000 - $1.04 Million
-10,000 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$77.66 - $99.74 $1.48 Million - $1.9 Million
-19,000 Reduced 65.52%
10,000 $925,000
Q3 2019

Nov 14, 2019
BUY
$90.37 - $122.49 $2.62 Million - $3.55 Million
29,000 New
29,000 $2.62 Million

Others Institutions Holding EXAS

# of Institutions
672
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email